Moreover, clinical analyses of TCGA database revealed low expression of FBXL2 and high expression of Grp94 in lung adenocarcinoma (LUAD) or lung squamous cell carcinoma (LUSC) (Supplementary Fig. 6b, c). This evidence concerns the gene HSP90B1 and squamous cell lung carcinoma.